Product Images Naloxone Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 13 images provide visual information about the product associated with Naloxone Hydrochloride NDC 50090-6710 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 (a) - 2Y2 Figure 1 (a)
.jpg "2Y2 Figure 1 (a).jpg")
Naloxone is a medication that is used to reverse the effects of opioid overdose. This document provides information on the plasma concentration of naloxone at different doses and routes of administration. It indicates that naloxone can be administered through nasal spray, with varying concentrations and quantities depending on the situation. Additionally, it mentions the option of intramuscular injection. The table shows the hours postdose for further evaluation of naloxone's effects.*
Figure 1 (b) - 2Y2 Figure 1 (b)
.jpg "2Y2 Figure 1 (b).jpg")
The text describes different dosage options and corresponding plasma concentrations of Naloxone, a medication used to reverse opioid overdose. The dosage options include 2 mg or 4 mg administered as a spray in the nostrils, with different concentrations of the medication solution. The text also mentions an alternative method of administration, which is a 0.4 mg intramuscular injection. The time points mentioned in the text may be related to the post-dose observation period.*
Step 3 - 2Y2 Step 3
Step 4 - 2Y2 Step 4
Step 5 - 2Y2 Step 5
Step 7 - 2Y2 Step 7
This text appears to describe the actions of a person's hands, knees, and body positioning. It suggests that the hands provide support for the head, while the knees prevent the body from rolling onto the stomach.*
label - Quick start image
The text describes a nasal spray medication called Naloxone HCI. It is intended for use in the nose only and requires a prescription (RxOnly). Each dose contains 4 mg of naloxone HCI, which is equivalent to 36 mg of naloxone, in a 0.1 mL nasal spray. The medication should be stored below 77°F (25°C) and should not be exposed to temperatures exceeding 104°F (40°C). It should also be protected from light. The spray is intended for use in cases of known or suspected overdose in adults. The text also includes a warning not to test the device before use.*
chemical structure - chemical structure
Step 2 - image 01
Label Image - lbl500906710
Step 1 - quick start guide step 1
Step 2 image 2 - quick start guide step 2 image 2
Step 3 - quick start guide step 3
This is not-readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.